… research subject. Her participation in Moderna’s Covid-19 mRNA vaccine trial and her engaging, first-hand advocacy to … platform to speak first-hand to her growing audience about mRNA vaccines, how they work, and what her experience was in … about how carefully the trial was performed and that mRNA vaccines were not developed ‘overnight’ but after 30 …